Azelon Pharmaceuticals

About:

Azelon Pharmaceuticals develops novel formulations for the treatment of osteoporosis.

Top Investors: Lighthouse Capital Partners, Prospect Venture Partners, Covington Funds

Description:

Azelon Pharmaceuticals, formerly Zelos Therapeutics, a West Conshohocken, PA-based company focused on the development of novel formulations for the treatment of osteoporosis.

Total Funding Amount:

$12.1M

Headquarters Location:

Conshohocken, Pennsylvania, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2012-03-16

IPO Status:

Private

Industries: